Artisan, Singapore's A-Bio Join Forces On Recombinant Sepsis Candidate
This article was originally published in PharmAsia News
Executive Summary
Artisan Pharma and Singapore-based A-Bio Pharma have established a relationship under which the Asian firm will provide process development, scale-up and manufacturing support for Artisan's investigational recombinant protein ART-123, the firms announced Sept. 17